Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Details) - Schedule of diluted net loss per share

v3.22.2.2
Net Loss per Share (Details) - Schedule of diluted net loss per share - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,161,913 881,308 1,161,913 881,308
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 118,388 118,388 118,388 118,388
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,043,525 762,920 1,043,525 762,920